Stay updated on PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial
Sign up to get notified when there's something new on the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page.

Latest updates to the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page
- Check3 days agoChange DetectedFooter revision badge updated from v3.6.0 to v3.6.2. This indicates a newer page template/version without altering the displayed study details or workflow.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page adds a recruitment-status note 'No longer looking for participants', indicating recruitment has ended. It also updates navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study), adjusts the Intervention/Treatment heading formatting, and adds a footer revision note 'Revision: v3.6.0'.SummaryDifference0.5%

- Check24 days agoChange DetectedThe page footer now displays Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a minor update to the study record page without altering core content.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision label updated to v3.5.4, indicating deployment of a new page version that replaces the previous v3.5.3.SummaryDifference0.1%

- Check67 days agoChange Detected ClinicalTrials.gov’s study page revision label was updated to a newer version (v3.5.3) from the previous one (v3.5.2).SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page.